摘要
N-acetyl cysteine(NAC)is a promising drug for prophylaxis and treatment of coronavirus disease 2019(COVID-19)based on antioxidant and anti-inflammatory mechanisms.Further studies with cautious approach are needed to establish the benefits and risks before considering NAC as an adjuvant treatment for COVID-19.
作者简介
Ajita Kapur,0000-0003-3449-6959;Munish Sharma,0000-0003-1334-5844;Corresponding author:Geetanjali Sageena,PhD,Assistant Professor,Environmental Studies,Keshav Mahavidyalaya University of Delhi,H-4-5 Zone Pitampura,New Delhi 110034,India.geetanjali.sageena@keshav.du.ac.in,0000-0001-7248-4356.
